| abstract |
VIRAL VECTORS AND PACKAGING CELL LINES. The disclosure generally relates to nucleic acid vectors and packaging cell lines for in vivo expansion of T cells. More particularly, the disclosure relates to direct intratumoral injection of a lentiviral vector adapted for drug-mediated transduction and expansion. of tumor-infiltrating lymphocytes in vivo. |